NORDIC BIOSCIENCE CLINICAL DEVELOPMENT VII A/S: Financial statements 2019
CVR: 33249098
Source: annual report 2019, Danish Business Authority
01/01/2019 – 31/12/2019
NORDIC BIOSCIENCE CLINICAL DEVELOPMENT VII A/S (CVR 33249098) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK 248,136 and a net result of DKK 164,772 compared with DKK 954,488 the year before. That is a decrease of 81.2% compared with the year before. Equity in the 2019 report amounted to DKK 725,098. The solvency ratio was 68.2%.
- Gross Profit
- DKK 248,136
- Profit/Loss
- DKK 164,772
- Equity
- DKK 725,098
- Total Assets
- DKK 1,063,281
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | - | 248 t. | 165 t. | 725 t. | 0 |
| 2018 | - | 1.3 mio. | 954 t. | 1.5 mio. | 0 |
| 2017 | - | 2.9 mio. | 2 mio. | 3 mio. | - |
| 2016 | - | 16 mio. | 11.1 mio. | 12 mio. | - |
| 2015 | - | 60.4 mio. | 45.4 mio. | 46 mio. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
As of September 26, 2019, Thomas Nielsen has left the board of directors of NORDIC BIOSCIENCE CLINICAL DEVELOPMENT VII A/S.
As of September 26, 2019, Morten Asser Karsdal has left the board of directors of NORDIC BIOSCIENCE CLINICAL DEVELOPMENT VII A/S.
As of September 26, 2019, Thomas Nielsen is registered as liquidator of NORDIC BIOSCIENCE CLINICAL DEVELOPMENT VII A/S.
As of September 26, 2019, Claus Henrik Christiansen has stepped down as chairman of NORDIC BIOSCIENCE CLINICAL DEVELOPMENT VII A/S.
As of September 26, 2019, Jeppe Ragnar Andersen has stepped down as adm. dir. of NORDIC BIOSCIENCE CLINICAL DEVELOPMENT VII A/S.
On September 26, 2019, NORDIC BIOSCIENCE CLINICAL DEVELOPMENT VII A/S entered liquidation.
NORDIC BIOSCIENCE CLINICAL DEVELOPMENT VII A/S has published its annual report for 2018. Gross profit came to DKK 1,317,781, and the net result was DKK 954,488.
About NORDIC BIOSCIENCE CLINICAL DEVELOPMENT VII A/S
NORDIC BIOSCIENCE CLINICAL DEVELOPMENT VII A/S was a Danish company of the type Aktieselskab based in Herlev, founded in 2010. The company has been dissolved on 25 May 2021. The company was registered under the industry Forskning og eksperimentel udvikling indenfor bioteknologi. According to the 2019 annual report, the company had an average of 0 employees. In 2019, the company reported a gross profit of DKK 248,136 and a net result of DKK 164,772 compared with DKK 954,488 the year before. Equity in the 2019 report amounted to DKK 725,098.